Dimensional Fund Advisors
KURA icon

Dimensional Fund Advisors’s Kura Oncology KURA Stock Holding History

Dimensional Fund Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.8M Sell
1,169,189
-256,756
-18% -$2.42M ﹤0.01% 2202
2026
Q1 		$11.6M Buy
1,425,945
+348,127
+32% +$2.99M ﹤0.01% 2202
2025
Q4 		$11.2M Sell
1,077,818
-61,547
-5% -$646K ﹤0.01% 2242
2025
Q3 		$10.1M Sell
1,139,365
-103,567
-8% -$738K ﹤0.01% 2301
2025
Q2 		$7.17M Sell
1,242,932
-119,492
-9% -$732K ﹤0.01% 2413
2025
Q1 		$8.99M Sell
1,362,424
-63,536
-4% -$495K ﹤0.01% 2298
2024
Q4 		$12.4M Buy
1,425,960
+372,196
+35% +$5.36M ﹤0.01% 2219
2024
Q3 		$20.6M Buy
1,053,764
+159,145
+18% +$3.22M 0.01% 1990
2024
Q2 		$18.4M Sell
894,619
-468,816
-34% -$9.64M ﹤0.01% 1997
2024
Q1 		$29.1M Sell
1,363,435
-638,319
-32% -$12.4M 0.01% 1797
2023
Q4 		$28.8M Buy
2,001,754
+197,530
+11% +$1.94M 0.01% 1795
2023
Q3 		$16.5M Sell
1,804,224
-107,432
-6% -$1.09M 0.01% 2022
2023
Q2 		$20.2M Buy
1,911,656
+76,572
+4% +$906K 0.01% 1925
2023
Q1 		$22.4M Buy
+1,835,084
New +$22.9M 0.01% 1844
2022
Q3 		$21.5M Buy
1,572,657
+193,042
+14% +$2.98M 0.01% 1787
2022
Q2 		$25.3M Buy
1,379,615
+308,930
+29% +$4.44M 0.01% 1734
2022
Q1 		$17.2M Buy
1,070,685
+296,175
+38% +$4.28M 0.01% 2039
2021
Q4 		$10.8M Buy
774,510
+124,269
+19% +$2.01M ﹤0.01% 2280
2021
Q3 		$12.2M Sell
650,241
-110,066
-14% -$2.07M ﹤0.01% 2238
2021
Q2 		$15.9M Sell
760,307
-58,785
-7% -$1.46M 0.01% 2159
2021
Q1 		$23.1M Buy
819,092
+170,582
+26% +$5.4M 0.01% 1966
2020
Q4 		$21.2M Buy
648,510
+26,046
+4% +$915K 0.01% 1953
2020
Q3 		$19.1M Buy
622,464
+30,369
+5% +$671K 0.01% 1883
2020
Q2 		$9.65M Buy
592,095
+39,186
+7% +$565K ﹤0.01% 2217
2020
Q1 		$5.5M Buy
552,909
+7,872
+1% +$90.1K ﹤0.01% 2371
2019
Q4 		$7.5M Buy
545,037
+7,180
+1% +$106K ﹤0.01% 2468
2019
Q3 		$8.16M Buy
537,857
+4,450
+0.8% +$79.2K ﹤0.01% 2436
2019
Q2 		$10.5M Buy
533,407
+142,414
+36% +$2.36M ﹤0.01% 2380
2019
Q1 		$6.49M Buy
390,993
+232,733
+147% +$3.59M ﹤0.01% 2563
2018
Q4 		$2.22M Buy
+158,260
New +$2.1M ﹤0.01% 2837

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Dimensional Fund Advisors's KURA Position: Q2 2026 in Review

Dimensional Fund Advisors reduced its Kura Oncology (KURA) stake by 18% in Q2 2026, selling an estimated $2.42M and leaving 1,169,189 shares worth $12.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2202.

Dimensional Fund Advisors first reported a position in KURA in Q4 2018 and has held it in 30 quarters since. The position peaked at $29.1M in Q1 2024. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Dimensional Fund Advisors held 1,169,189 shares of Kura Oncology worth $12.8M as of Q2 2026.
  • Dimensional Fund Advisors sold 256,756 Kura Oncology shares in Q2 2026, an estimated $2.42M.
  • Kura Oncology made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2202 holding.
  • Dimensional Fund Advisors first reported a position in Kura Oncology in Q4 2018 and has held it in 30 quarters since.
  • Dimensional Fund Advisors's Kura Oncology position peaked at $29.1M in Q1 2024.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.